治療抗体の存在下におけるFcγRIIIa関与によるヒトナチュラルキラー細胞事象の評価

0:27

Antibody-Mediated Activation of NK Cells

3:12

Interrogation of Signaling Molecules by Western Blot Analysis

3:47

Isolation of mRNA and Preparation for Chemokine/Cytokine Assessment

4:39

Cytoskeletal Rearrangement Assessment

5:57

Assessing Degranulation Using CD107a Surface Staining

7:10

Results: Downstream Applications of NK Cell Activation Assay

9:20

Conclusion